Famitinib
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for Famitinib, covering 2018-04-17 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma [Phase 2]